Canine-mediated rabies in humans Infections and Infestations
Conditions
Interventions
We will test the efficacy of a novel mass dog rabies vaccination (MDRV) delivery strategy called community-led continuous delivery versus the existing team-led pulsed delivery strategy. To test this w
Sponsors
Washington State University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People who live in the target areas
Exclusion criteria
Exclusion criteria: People who do not live or travel through the target areas
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The proportion of dogs in each community (village) that have been vaccinated. A dog will be considered vaccinated if, on post-vaccination coverage monitoring, it is found to have a microchip when scanned using a handheld digital scanner. Only dogs vaccinated in this study will have a microchip, as this technology is not otherwise used in Tanzania. 2. Number of human dog-bite injuries assessed using hospital record data collected at district hospitals in the Mara region of Tanzania from October 2019 to August 2023 3. Number of human rabies cases assessed using hospital record data collected at district hospitals in the Mara region of Tanzania from October 2019 to August 2023 | — |
Secondary
| Measure | Time frame |
|---|---|
| Cost of the delivery strategy per dog vaccinated | — |
Countries
Tanzania
Contacts
Public ContactFelix Lankester
Outcome results
None listed